Xuebiao Yao to Case-Control Studies
This is a "connection" page, showing publications Xuebiao Yao has written about Case-Control Studies.
Connection Strength
0.226
-
Jiang HY, Huang TB, Xu L, Yu J, Wu Y, Geng J, Yao XD. Aspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis. PLoS One. 2015; 10(4):e0122962.
Score: 0.101
-
Guo X, Lv X, Fang C, Lv X, Wang F, Wang D, Zhao J, Ma Y, Xue Y, Bai Q, Yao X, Chen Y. Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling. Int J Cancer. 2016 10 15; 139(8):1821-9.
Score: 0.028
-
Zhang QH, Li AM, He SL, Yao XD, Zhu J, Zhang ZW, Sheng ZY, Yao YM. Serum Total Cholinesterase Activity on Admission Is Associated with Disease Severity and Outcome in Patients with Traumatic Brain Injury. PLoS One. 2015; 10(6):e0129082.
Score: 0.026
-
Hu YY, Dong WD, Xu YF, Yao XD, Peng B, Liu M, Zheng JH. Elevated levels of miR-155 in blood and urine from patients with nephrolithiasis. Biomed Res Int. 2014; 2014:295651.
Score: 0.024
-
Zhu W, Liu M, Wang GC, Peng B, Yan Y, Che JP, Ma QW, Yao XD, Zheng JH. Fibrinogen alpha chain precursor and apolipoprotein A-I in urine as biomarkers for noninvasive diagnosis of calcium oxalate nephrolithiasis: a proteomics study. Biomed Res Int. 2014; 2014:415651.
Score: 0.024
-
Sun W, Feng Y, Yao XD, Xu YF, Peng B, Liu M, Zheng JH. Urinary angiotensinogen is elevated in patients with nephrolithiasis. Biomed Res Int. 2014; 2014:349602.
Score: 0.024